ImmunoGen (IMGN) Stock Forecast for 2024–2028. Sell or Buy Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

ImmunoGen (IMGN) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 29, 2024 (08:16)

Sector: Healthcare

The share price of ImmunoGen, Inc. (IMGN) now

Latest session on the 26th of February for
ImmunoGen, Inc. is negative
Trading Volume: 40
Open: 31.23 /  High: 31.23 /  Low: 31.23
What analysts predict: $25.5
52-week High/Low: $31.25 / $3.66

50/200 Day Moving Average: $29.71 / $19.72

This figure corresponds to the Average Price over the previous 50/200 days. For ImmunoGen stocks, the 50-day moving average is the support level today.

For ImmunoGen stocks, the 200-day moving average is the support level today.

Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2024, 2025, 2026, 2027, 2028. How much will one ImmunoGen share be worth in 2024 - 2028?

When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.


Historical and forecast chart of ImmunoGen stock

The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.

Long-term forecasts by years.

ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.

ImmunoGen daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 31 31.14 30.59 31.59 3.28
Apr 01 30.98 30.64 31.46 2.65
Apr 02 31.18 30.72 31.69 3.17
Apr 03 31.03 30.68 31.59 2.98
Apr 04 31.34 30.80 31.56 2.48
Apr 05 32.03 31.52 32.45 2.97
Apr 06 31.80 31.65 32.34 2.17
Apr 07 32.11 31.59 32.43 2.67
Apr 08 31.70 31.55 32.20 2.06
Apr 09 32.00 31.78 32.39 1.90
Apr 10 31.54 31.21 32.08 2.77
Apr 11 31.95 31.37 32.30 2.95
Apr 12 32.42 32.18 32.90 2.25
Apr 13 32.79 32.35 33.00 2.00
Apr 14 33.12 32.55 33.66 3.39
Apr 15 33.41 33.20 33.97 2.29
Apr 16 33.12 32.67 33.64 2.96
Apr 17 33.26 32.72 33.67 2.90
Apr 18 33.26 33.04 33.81 2.34
Apr 19 33.36 32.83 33.89 3.22
Apr 20 33.23 32.78 33.46 2.08
Apr 21 33.27 32.81 33.56 2.29
Apr 22 33.46 32.97 33.66 2.10
Apr 23 33.38 33.05 33.77 2.18
Apr 24 33.13 32.54 33.47 2.86
Apr 25 33.55 33.19 33.79 1.81
Apr 26 33.58 33.20 34.05 2.56
Apr 27 33.48 33.24 34.04 2.43
Apr 28 33.30 33.12 33.86 2.22
Apr 29 32.68 32.11 32.85 2.32

ImmunoGen Daily Price Targets


ImmunoGen Stock Forecast 03-31-2024.

Forecast target price for 03-31-2024: $31.14.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 3.173%.
Pessimistic target level: 30.59
Optimistic target level: 31.59

ImmunoGen Stock Forecast 04-01-2024.

Forecast target price for 04-01-2024: $30.98.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.582%.
Pessimistic target level: 30.64
Optimistic target level: 31.46

ImmunoGen Stock Forecast 04-02-2024.

Forecast target price for 04-02-2024: $31.18.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 3.077%.
Pessimistic target level: 30.72
Optimistic target level: 31.69

ImmunoGen Stock Forecast 04-03-2024.

Forecast target price for 04-03-2024: $31.03.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.892%.
Pessimistic target level: 30.68
Optimistic target level: 31.59

ImmunoGen Stock Forecast 04-04-2024.

Forecast target price for 04-04-2024: $31.34.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.421%.
Pessimistic target level: 30.80
Optimistic target level: 31.56

ImmunoGen Stock Forecast 04-05-2024.

Forecast target price for 04-05-2024: $32.03.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.883%.
Pessimistic target level: 31.52
Optimistic target level: 32.45

IMGN (IMGN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 33.85 31.16 35.17 11.41
May. 38.88 34.62 40.81 15.15
Jun. 37.71 33.87 41.67 18.73
Jul. 33.36 29.81 36.41 18.14
Aug. 34.01 30.69 35.59 13.76
Sep. 33.86 29.95 35.58 15.84
Oct. 38.83 34.76 42.62 18.45
Nov. 36.04 34.20 38.69 11.60
Dec. 33.33 30.93 36.93 16.25

ImmunoGen forecast for this year


ImmunoGen Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $33.8533. Pessimistic: $31.16. Optimistic: $35.17


ImmunoGen Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $38.8805. Pessimistic: $34.62. Optimistic: $40.81


ImmunoGen Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $37.7141. Pessimistic: $33.87. Optimistic: $41.67


ImmunoGen Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $33.3581. Pessimistic: $29.81. Optimistic: $36.41


ImmunoGen Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $34.0086. Pessimistic: $30.69. Optimistic: $35.59


ImmunoGen Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $33.8556. Pessimistic: $29.95. Optimistic: $35.58


ImmunoGen Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $38.8324. Pessimistic: $34.76. Optimistic: $42.62


ImmunoGen Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $36.0364. Pessimistic: $34.20. Optimistic: $38.69


ImmunoGen Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $33.3337. Pessimistic: $30.93. Optimistic: $36.93



ImmunoGen (IMGN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 32.18 29.24 34.36 14.89
Feb 28.61 26.12 30.16 13.38
Mar 28.83 25.67 31.46 18.42
Apr 26.88 24.14 30.07 19.71
May 25.55 24.28 28.39 14.45
Jun 27.70 24.41 29.44 17.07
Jul 28.07 24.83 30.30 18.06
Aug 31.73 28.73 33.87 15.18
Sep 29.54 26.22 32.78 20.01
Oct 32.29 31.32 35.87 12.69
Nov 32.78 29.73 34.45 13.70
Dec 30.02 27.64 32.81 15.78

ImmunoGen (IMGN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 31.15 30.21 34.42 12.22
Feb 31.99 29.64 35.30 16.04
Mar 29.97 27.64 33.48 17.46
Apr 30.11 29.21 31.87 8.36
May 28.35 26.90 31.20 13.77
Jun 31.88 29.68 33.36 11.04
Jul 29.29 27.32 31.54 13.38
Aug 26.26 24.25 28.51 14.92
Sep 26.22 23.59 28.66 17.70
Oct 23.63 22.03 26.07 15.50
Nov 21.96 21.04 24.33 13.54
Dec 20.74 18.53 23.17 20.01

ImmunoGen (IMGN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 19.72 17.56 20.60 14.78
Feb 22.41 21.16 24.09 12.14
Mar 21.36 19.63 23.45 16.26
Apr 22.07 19.88 24.12 17.57
May 24.19 21.39 27.02 20.81
Jun 26.22 24.88 28.93 14.00
Jul 27.48 26.41 29.70 11.10
Aug 28.88 26.58 32.22 17.48
Sep 29.27 27.73 31.90 13.07
Oct 27.91 24.94 30.34 17.80
Nov 27.66 25.42 30.89 17.73
Dec 25.58 22.67 26.50 14.48

ImmunoGen (IMGN) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 26.93 23.86 29.92 20.25
Feb 30.97 29.76 33.89 12.20
Mar 32.36 30.08 33.82 11.05
Apr 30.85 28.82 32.75 12.01
May 33.54 31.83 36.96 13.88
Jun 35.15 30.98 36.94 16.13
Jul 33.94 30.68 36.33 15.55
Aug 35.46 34.29 37.64 8.90
Sep 36.85 32.54 38.45 15.38
Oct 31.71 28.09 32.80 14.35
Nov 29.47 27.30 31.99 14.65
Dec 27.53 25.63 28.64 10.52

ImmunoGen information and performance

ImmunoGen Address

830 WINTER ST, WALTHAM, MA, US

Market Capitalization: 8 724 225 000 $

Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.

EBITDA: -78 459 000 $

EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.28

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 4.078
Quarterly Revenue Growth YOY: 6.38
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 156.25

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 28.52

Enterprise Value (EV) /Revenue

EV To EBITDA: -134.36

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 279354000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.